The Stop Insider Trading Act (H.R.7008)

Information has always been one of the most valuable commodities in the financial markets. As investors and traders, we spend countless hours studying charts, earnings reports and economic data looking for anything that might help us make a better decision.

But what happens when someone has access to information the rest of us simply cannot access?

That question has been debated for years, and now Congress may finally be taking another step toward addressing it.

On July 22, 2026, the House of Representatives passed H.R. 7008, the Stop Insider Trading Act, by a vote of 232–198. The legislation would place significant new restrictions on members of Congress and certain family members when it comes to buying individual stocks.

So, what would really change?

Under the House-passed legislation, members of Congress, their spouses and dependent children would generally be prohibited from purchasing securities issued by publicly traded companies and certain comparable investments.

If Congress prohibited a senator or representative from purchasing stock but allowed those same investments to simply be purchased through a spouse or child, we really wouldn’t have solved much.

You may hear this called a “Congressional stock trading ban,” but that doesn’t tell the whole story.

Covered individuals would generally be prohibited from making new purchases, but they would not automatically be required to sell investments they already own. They could continue holding existing positions.

If they decide to sell a covered investment, the legislation generally requires advance public disclosure of the intended sale at least seven days, but no more than 14 days, before the transaction.

Violating the rules could also become expensive. Penalties could include $2,000 or 10% of the value of the violating transaction, whichever is greater, along with forfeiture of net gains as calculated under the legislation.

SO…Who is actually impacted by the new legislation—and who is not?

The primary people impacted are members of the House and Senate, along with their spouses and dependent children. This particular legislation does not broadly impose the same stock-purchase ban on the following executive-branch officials: President, Vice President, Cabinet secretaries and other senior administration officials. The distinction is that H.R. 7008 was written specifically around congressional trading. It does not create one universal stock-trading prohibition covering everyone at the highest levels of government.

And that raises an interesting question. If a member of Congress may have an informational advantage because of classified briefings, committee hearings or pending legislation, shouldn’t we at least ask the same question about officials helping shape tariffs, defense contracts, energy policy, pharmaceutical regulation or technology policy?

Congress has debated this issue before. In 2012, Congress passed the STOCK Act, making it clear that members of Congress and congressional employees are subject to insider-trading restrictions while strengthening financial disclosure requirements.

Yet the controversy was never really resolved. Whenever a politician makes an unusually well-timed trade around a major government announcement, people naturally ask questions. A profitable trade by itself does not prove wrongdoing. That distinction is important. But there is another issue at stake: public confidence.

So, what happens next? The House has passed the legislation, but that is not the end of the line. The legislation must now make its way through the Senate, where senators could consider it as written, modify it or pursue different language. If the Senate changes the bill, the House and Senate would ultimately have to agree on identical legislative language, and then a final bill could be sent to the President to be signed into law or vetoed.

There is a potential issue; The final House-passed legislation was combined with federal voter-identification provisions, adding another political dimension that could affect its path through the Senate. For the average investor, this legislation does not change our ability to buy and sell stocks. But it could change the ways average people follow politicians’ trades. There are now websites and investment tools designed to track congressional trading transactions. If lawmakers and their immediate families can no longer freely purchase individual stocks that these strategies may no longer work.

But I think there is a bigger message here.There will always be investors with better research, more experience, more capital or better technology. That is part of the financial markets. However, privileged access to government information is something entirely different. If Washington ultimately decides members of Congress should not purchase individual stocks because of the information and influence that comes with public office, perhaps the next question is obvious: Shouldn’t the same standard apply to everyone serving in any branch of the government?!

The House has made its move. Now it’s off to the Senate.